Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.40 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.40 |
| ▸ | MDK | P21741 | 3/20 | 0.38 |
| ▸ | BDNF | P23560 | 3/20 | 0.38 |
| ▸ | PTN | P21246 | 2/20 | 0.38 |
| ▸ | CD69 | Q07108 | 1/20 | 0.38 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.36 |
| ▸ | MAG | P20916 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.35 |
| ▸ | FGF1 | P05230 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24036351 | 0.93 | MAPK1 (0.44) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL25964185 | 0.91 | MAPK1 (0.45) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL25963112 | 0.87 | MAPK1 (0.47) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL20235169 | 0.87 | MAPK1 (0.49) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL14089004 | 0.85 | MAPK1 (0.57) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL26473755 | 0.84 | ALDH1A1 (0.47) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL12580633 | 0.83 | ALDH1A1 (0.52) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL18608138 | 0.82 | LGALS3 (0.43) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL18608226 | 0.82 | LGALS3 (0.43) | MAPK1ALDH1A1THRBLGALS3LGALS8 | |
| SCHEMBL23322444 | 0.82 | LGALS3 (0.43) | MAPK1ALDH1A1THRBLGALS3LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100210587-A1 | Swellable Crosslinked Hyaluronan Powder And Method For Producing The Same | SHISEIDO COMPANY LTD. (JP) | 2010-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210587-A1 | Swellable Crosslinked Hyaluronan Powder And Method For Producing The Same | CD44, H1-0, MUC1 | MAPK1 2503/4885ALDH1A1 391/4885THRB 4784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.